Displaying 1 - 1 of 1
| Active Ingredient | ANTI-D IMMUNOGLOBULIN |
| Therapeutic Class | SERUMS |
| Indications | Prevention of D (RhO) sensitisation in RhD negative women. |
| Caution | Risk of sensitization. |
| Dose Range |
Routine antenatal prophylaxis: 2 doses of 500 units given at weeks 28 and 34 gestation. Postnatal prophylaxis is still necessary. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |